Cargando…
The Risk of Febrile Seizures Following Influenza and 13-Valent Pneumococcal Conjugate Vaccines
BACKGROUND: Evidence on the risk of febrile seizures (FS) after vaccination with inactivated influenza vaccine (IIV) and 13-valent pneumococcal conjugate vaccine (PCV13) is mixed. Among children 6–23 months, we examined the risk of FS following IIV and PCV13 during the 2013–14 and 2014–15 influenza...
Autores principales: | Baker, Meghan, Jankosky, Christopher, Yih, Katherine, Gruber, Susan, Li, Lingling, Cocoros, Noelle, Lipowicz, Hana, Coronel-Moreno, Claudia, Feibelmann, Sandra, Lin, Nancy, McMahill-Walraven, Cheryl, Menschik, David, Selvan, Mano, Selvam, Nandini, Tilney, Rong Chen, Zichittella, Lauren, Lee, Grace, Kawai, Alison Tse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630778/ http://dx.doi.org/10.1093/ofid/ofx163.1187 |
Ejemplares similares
-
1070 Validation of Febrile Seizures Identified in the Mini-Sentinel Post-Licensure Rapid Immunization Safety Monitoring (PRISM) System
por: Kawai, Alison Tse, et al.
Publicado: (2014) -
Kawasaki disease and 13-valent pneumococcal conjugate vaccination among young children: A self-controlled risk interval and cohort study with null results
por: Baker, Meghan A., et al.
Publicado: (2019) -
Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System
por: Yih, Weiling Katherine, et al.
Publicado: (2015) -
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
por: Shiramoto, Masanari, et al.
Publicado: (2015) -
Persistence of antibodies 1 year after sequential administration of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in adults
por: Schmoele-Thoma, Beate, et al.
Publicado: (2019)